| UCB Pharmaceuticals Jobs Profile
This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for UCB Pharmaceuticals. Company Overview UCB is a global biopharmaceutical leader with headquarters in Brussels, Belgium. It combines the global infrastructure and expertise of a traditional Pharma company with the speed, innovation and entrepreneurship of a biotech company. UCB employs over 8,500 people operating in over 40 countries worldwide. Mission To provide novel therapeutic solutions for patients with severe diseases treated by specialists, particularly in the fields of central nervous system disorders (including epilepsy), inflammatory disorders (including allergy) and oncology. UCB's medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field. Product Overview - Keppra® (levetiracetam) is indicated as add-on antiepilepsy treatment for adults and children from 4 years of age with partial onset seizures.
- Nootropil® (piracetam) is a cerebral function regulator, used to treat adults and the elderly.
- Xyzal® (levocetirizine) is an antihistamine treatment for symptoms associated with allergic conditions such as seasonal allergic rhinitis (including ocular symptoms), perennial allergic rhinitis, chronic idiopathic urticaria.
- Zyrtec® (cetirizine) is an antihistamine treatment for the symptoms of perennial allergic rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria. In the US Zyrtec® is licensed and co-promoted with Pfizer Inc.
- TussionexTM (hydrocodone polistirex and chlorpheniramine polistirex) (CIII) is used for relief of cough and upper respiratory symptoms associated with allergy or cold.
- Metadate-CDTM / EquasymTM (methylphenidate HCl) (CII) is used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
- Neupro® (rotigotine) is a transdermal patch used in the treatment of Parkinson's Disease in adults and elderly.
- UnivascTM/FemipresTM/PerdixTM is indicated for the treatment of essential hypertension in adults and elderly.
- Edex®/Viridal® is indicated in erectile dysfunction in adults and elderly.
Deponit® (glyceryl trinitrate) is indicated in the treatment of coronary heart disease in adults and elderly. - Isoket® (isosorbide dinitrate) is used for the treatment of angina and heart failure in adults and elderly.
 
|  |  |  | Nikki UCB Pharmaceuticals Account Manager 01494 818032 (Mon to Fri 0830 to 1800 hours) nikki@zenopa.com
|
|

Please contact the Account Manager for opportunities with this organisation
News
UCB Pharmaceuticals sells bioproducts division for 120m euros UCB Pharmaceuticals is to sell its bioproducts manufacturing division to Swiss firm Lonza for 120 million euros.
UCB Pharmaceuticals confirms positive outlook Brussels-based UCB Pharmaceuticals has confirmed net income after tax for 2005 will be at least ?260 million.
|